Inspire Medical Systems Inc. Stock News

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Today, we take a deeper look at Inspire Medical Systems, Inc., a medical device manufacturer focused on solutions for obstructive sleep apnea. Despite stellar revenue growth and a rock-solid balance s

September-quarter earnings among medical-device makers may prove better than expected in the age of weight-loss drugs.

MINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2023 after the close of trading on Tuesday, Nov

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

MINNEAPOLIS, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima

Inspire Medical Systems has performed well in 2023 with its hyperglossal nerve stimulation design for sleep apnea sufferers. The company plans to release a version without a sensor lead in 2024, makin

Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the second quarter.

Inspire Medical Systems, Inc. (NYSE:INSP ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & C

While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to

Inspire Medical Systems (INSP) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.53 per share a year ago.

Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA c

Inspire Medical Systems NYSE: INSP is up nearly 15% since breaking out of cup-with-handle base on May 3. The base's buy point was above $277.18, which you can see on the Inspire Medical Systems chart.

MINNEAPOLIS, July 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2023 after the close of trading on Tuesday, Au

Investors are optimistic about Inspire Medical's (INSP) global presence.